Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology
The article briefly describes the inhibitor of angiotensin converting enzyme (ACEI) - fosinopril, calcium channel blocker - diltiazem and antiplatelet agent- acetylsalicylic acid (ASA). The mechanism of their action and possible side effects are given. The authors of the article described in detail...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Concilium Medicum
2018-03-01
|
| Series: | КардиоСоматика |
| Subjects: | |
| Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45960/pdf |
| _version_ | 1818600563959398400 |
|---|---|
| author | V. S Zadionchenko G. G Shekhyan A. A Yalymov A. M Shchikota S. A Terpigorev T. G Kabanova A. M Nikishenkov |
| author_facet | V. S Zadionchenko G. G Shekhyan A. A Yalymov A. M Shchikota S. A Terpigorev T. G Kabanova A. M Nikishenkov |
| author_sort | V. S Zadionchenko |
| collection | DOAJ |
| description | The article briefly describes the inhibitor of angiotensin converting enzyme (ACEI) - fosinopril, calcium channel blocker - diltiazem and antiplatelet agent- acetylsalicylic acid (ASA). The mechanism of their action and possible side effects are given. The authors of the article described in detail the antihypertensive drug from the group ACEI - fosinopril, antiplatelet agent - ASA and non-hydropyridine calcium channel blocker - diltiazem. The results of multicenter randomized trials of ASA, fosinopril in patients with arterial hypertension, ischemic heart disease, nephropathy and heart failure are presented. The article presents a clinical example that demonstrates the selection of the optimal drugs for the treatment of the combined pathology of the heart and kidneys, and also provides an evidence base for the efficacy and safety of fosinopril and ASA preparations. Presented drugs (ASA, fosinopril, diltiazem) are highly effective in all categories of patients with CVD and can be recommended for wider clinical use. |
| first_indexed | 2024-12-16T12:37:29Z |
| format | Article |
| id | doaj.art-c579f7869c5b47bfa1c54f5dad998109 |
| institution | Directory Open Access Journal |
| issn | 2221-7185 2658-5707 |
| language | English |
| last_indexed | 2024-12-16T12:37:29Z |
| publishDate | 2018-03-01 |
| publisher | Concilium Medicum |
| record_format | Article |
| series | КардиоСоматика |
| spelling | doaj.art-c579f7869c5b47bfa1c54f5dad9981092022-12-21T22:31:32ZengConcilium MedicumКардиоСоматика2221-71852658-57072018-03-0191546010.26442/2221-7185_2018.1.54-6041597Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathologyV. S Zadionchenko0G. G Shekhyan1A. A Yalymov2A. M Shchikota3S. A Terpigorev4T. G Kabanova5A. M Nikishenkov6A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian FederationA.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian FederationA.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian FederationA.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian FederationM.F.Vladimirskiy Moscow Regional Research Clinical InstituteM.F.Vladimirskiy Moscow Regional Research Clinical InstituteM.F.Vladimirskiy Moscow Regional Research Clinical InstituteThe article briefly describes the inhibitor of angiotensin converting enzyme (ACEI) - fosinopril, calcium channel blocker - diltiazem and antiplatelet agent- acetylsalicylic acid (ASA). The mechanism of their action and possible side effects are given. The authors of the article described in detail the antihypertensive drug from the group ACEI - fosinopril, antiplatelet agent - ASA and non-hydropyridine calcium channel blocker - diltiazem. The results of multicenter randomized trials of ASA, fosinopril in patients with arterial hypertension, ischemic heart disease, nephropathy and heart failure are presented. The article presents a clinical example that demonstrates the selection of the optimal drugs for the treatment of the combined pathology of the heart and kidneys, and also provides an evidence base for the efficacy and safety of fosinopril and ASA preparations. Presented drugs (ASA, fosinopril, diltiazem) are highly effective in all categories of patients with CVD and can be recommended for wider clinical use.https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45960/pdfangiotensin-converting enzyme inhibitorfosinoprilcalcium channel blockerdiltiazemantiplatelet agentsacetylsalicylic acidarterial hypertensionnephropathyheart failuremyocardial infarction |
| spellingShingle | V. S Zadionchenko G. G Shekhyan A. A Yalymov A. M Shchikota S. A Terpigorev T. G Kabanova A. M Nikishenkov Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology КардиоСоматика angiotensin-converting enzyme inhibitor fosinopril calcium channel blocker diltiazem antiplatelet agents acetylsalicylic acid arterial hypertension nephropathy heart failure myocardial infarction |
| title | Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| title_full | Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| title_fullStr | Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| title_full_unstemmed | Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| title_short | Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| title_sort | clinical case the experience of using acetylsalicylic acid fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology |
| topic | angiotensin-converting enzyme inhibitor fosinopril calcium channel blocker diltiazem antiplatelet agents acetylsalicylic acid arterial hypertension nephropathy heart failure myocardial infarction |
| url | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45960/pdf |
| work_keys_str_mv | AT vszadionchenko clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT ggshekhyan clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT aayalymov clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT amshchikota clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT saterpigorev clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT tgkabanova clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology AT amnikishenkov clinicalcasetheexperienceofusingacetylsalicylicacidfosinoprilanddiltiazeminthetherapyofapatientwithcardiovascularpathology |